Research to improve people's health

foto UEM 2 web idiap 17

Medicines Study Unit (UEM)

 

About:  

The Medicines Study Unit (UEM) undertakes the design, coordination and monitoring of research with medicines. The UEM interacts with other sectors and researchers of the IDIAPJGol.

The UEM is amember of SCReN (Spanish Clinical Research Network
), a platform that supports clinical research, in particular multicentre clinical trials, constituted by 29 research units (UICEC – Unidad de Investigación Clínica y Ensayos Clínicos) in 11 autonomous communities.

The main responsabilities of the UEM are:

  • Independent clinical trials: legal, administrative, methodological, statistical and data management support, pharmacovigilance, monitoring and management of medicines.
  • Support in the global management of non-independent clinical trials.
  • CEI: new circuits in accordance with the RD 1090/2015, supervision, technical and administrative office, evaluation.
  • Observational studies (pharmacoepidemiology and pharmacovigilance, PASS studies required by the risk management plans of the EMA) with the SIDIAP: SIDIAP scientific committee, technical, methodological, statistical and scientific support.
  • Development of other research projects with medicines.

 

Members: 

 

Rosa Morros, coordinator
93 482 41 17
This email address is being protected from spambots. You need JavaScript enabled to view it.

Ramon Monfà, monitor and trials coordinator
93 482 46 51
This email address is being protected from spambots. You need JavaScript enabled to view it.

Ana García, monitor and trials coordinator
93 482 46 44
This email address is being protected from spambots. You need JavaScript enabled to view it.

Maria Giner, scientific and methodologic support
93 482 41 10
This email address is being protected from spambots. You need JavaScript enabled to view it.

Ainhoa Gómez, pharmacovigilance
93 482 46 0517
This email address is being protected from spambots. You need JavaScript enabled to view it. 

Carles Vilaplana, data analyst 
93 482 46 51
This email address is being protected from spambots. You need JavaScript enabled to view it.

Silvia Fernández, pharmacovigilance
93 482 46 51
This email address is being protected from spambots. You need JavaScript enabled to view it.

Cristina Miranda, monitor and trials coordinator
93 482 46 51
This email address is being protected from spambots. You need JavaScript enabled to view it.